IMUX Immunic Inc: Net earnings per share for the last 12 months
This price chart illustrates the profit dynamics of Immunic, Inc. (IMUX), which currently stands at 47.50. Immunic, Inc. (IMUX) is implementing bioinformatics for the computational design of molecules targeting autoimmune pathologies to minimize manual labor. However, political fragmentation is hindering raw material procurement and global testing. Costs associated with the final stage of sclerosis drug trials and the potential for equity dilution remain significant burdens.
Immunic Therapeutics - analytical breakdowns and key metrics (IMUX)
- market value and analyst target forecast:
- company stock capitalization data:
- book capitalization data:
- debt burden and liquidity indicators:
- earnings and multiples data:
IMUX - Company Net Income|Net Profit Forecast Immunic, Inc.|IMUX - P/E Multiple|Market Cap to Projected Earnings immunic-therapeutics.com|IMUX - PEG Multiple|Enterprise Value to EBITDA Ratio Immunic|IMUX - Operating profit before deduction of amortization|Earnings per share for the trailing year Immunic|IMUX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months immunic-therapeutics.com|IMUX - Earnings per share growth in current year|Projected earnings per share growth rate for next year Immunic, Inc.
- revenue and sales details:
Initial company analysis:Immunic, Inc.
This indicator measures the annual growth rate of net income per share over a rolling four-quarter period, allowing for an assessment of capital generation efficiency without reporting time lags. By analyzing the annual trend of the EPS TTM metric, an investor can forecast the revenue stability of Immunic, Inc. (IMUX), whose lifetime therapy model for multiple sclerosis is designed to ensure stable and long-term profit growth.
Competitor analysis
argenx N.V. (ARGX) - Net earnings per share for the last 12 months|BioNTech Pharma (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) protagonist-inc.com|Earnings per share for the last twelve months Immunovant Corp (IMVT)|Kiniksa - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Net earnings per one share for the last twelve months|celldex.com - Net earnings per share (EPS TTM)|AUPH - Net earnings per share (EPS TTM)|BCRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vera Therapeutics Inc (VERA)|DNTH (Dianthus Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Pharvaris Pharma|Net earnings per share (EPS TTM) ABCL|TRML (tourmalinebio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PGEN (Precigen Inc)|PHAR - Net earnings per share for the last 12 months|NKTR - Earnings per share for the last twelve months|UPB - Net earnings per share (EPS TTM)|ZBIO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Immunome, Inc.|Earnings per share for the last twelve months Gossamer Bio|Net earnings per share (EPS TTM) KalVista Pharmaceuticals Inc|Net earnings per share for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SVRA (savarapharma.com)|Earnings per share for the trailing year RIGL|ANAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ATXS (Astria Therapeutics, Inc.)|ENGN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Earnings per share for the last twelve months aerovatetx.com|Net earnings per share (EPS TTM) aclaristx.com|Earnings per share for the last twelve months Kyverna Therapeutics (KYTX)|Net earnings per share for the last four quarters Tiziana Life Sciences Ltd|Net earnings per share (EPS TTM) CABA (Cabaletta Bio Inc)|VTYX: Earnings per share for the last 12 months|Theratechnologies, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Net earnings per share for the last 12 months|Agenus Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Climb Bio|Net earnings per share (EPS TTM) Zura Bio Ltd|Net earnings per share for the last 12 months ATYR (aTyr Pharma Inc)|Net earnings per share for the last four quarters Adagene Inc|Earnings per share for the last twelve months ImageneBio Inc IMA|Earnings per share for the last four quarters STTK (shattucklabs.com)|EQ: Net earnings per share for the last 12 months|CNTB: Earnings per share for the last twelve months|ATRA: Net earnings per share (EPS TTM)|InflaRx N.V. (IFRX) - Net earnings per share (EPS TTM)|Earnings per one share for the last 12 months x4pharma.com XFOR|Net earnings per share for the last 12 months adicetbio.com (ACET)|Earnings per share for the last twelve months Celularity Inc (CELU)|Net earnings per share for the last 12 months INmune Bio Corp INMB|Earnings per share for the last twelve months barinthusbio.com BRNS|Earnings per share for the trailing year KZR|sabbiotherapeutics.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year AKTX (Akari Therapeutics PLC)|ENLV: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months QTTB|GOVX (geovax.com) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Edesa Biotech|Net earnings per share (EPS TTM) IBIO|Net earnings per share for the last 12 months Carisma Therapeutics Inc. CARM|Earnings per share for the last twelve months XTL Biopharmaceuticals, Ltd. XTLB|Net earnings per share (EPS TTM) boltbio.com BOLT|HCWB - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Aptevo Therapeutics Inc. APVO|AIM ImmunoTech, Inc. (AIM) - Earnings per share for the last twelve months|ADTX: Earnings per share for the last four quarters|GRI (GRI Bio Corporation) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) XORTX Therapeutics Inc.|Earnings per share for the last twelve months Vyome Holdings (HIND)|Net earnings per share for the last four quarters revbiosciences.com|Earnings per share for the last twelve months Indaptus Therapeutics Inc INDP|Net earnings per share (EPS TTM) Scinai SCNI|CALI - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AFMD|ALLK (Allakos Therapeutics) - Net earnings per share for the last 12 months|HOOKIPA - Earnings per share for the trailing year|IGMS (IGM Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iTeos Therapeutics Inc ITOS|Earnings per share for the last twelve months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TC Biopharm TCBP|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc.)
